Recursion Pharmaceuticals Inc (NASDAQ:RXRX) has a beta value of 0.84 and has seen 21.11 million shares traded in the last trading session. The company, currently
During the last session, Recursion Pharmaceuticals Inc (NASDAQ:RXRX)’s traded shares were 34.95 million, with the beta value of the company hitting 0.84. At the end
Recursion Pharmaceuticals Inc (NASDAQ:RXRX)’s traded shares stood at 32.88 million during the last session, with the company’s beta value hitting 0.87. At the close of
In the last trading session, 59.74 million Recursion Pharmaceuticals Inc (NASDAQ:RXRX) shares changed hands as the company’s beta touched 0.83. With the company’s per share
During the last session, Recursion Pharmaceuticals Inc (NASDAQ:RXRX)’s traded shares were 21.49 million, with the beta value of the company hitting 0.86. At the end
In today’s recent session, 7.24 million shares of the Recursion Pharmaceuticals Inc (NASDAQ:RXRX) have been traded, and its beta is 0.89. Most recently the company’s
Recursion Pharmaceuticals Inc (NASDAQ:RXRX)’s traded shares stood at 16.52 million during the last session, with the company’s beta value hitting 0.86. At the close of
In the last trading session, 14.01 million Recursion Pharmaceuticals Inc (NASDAQ:RXRX) shares changed hands as the company’s beta touched 0.85. With the company’s per share
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne